Stay updated on Semaglutide Effectiveness in Obesity Clinical Trial

Sign up to get notified when there's something new on the Semaglutide Effectiveness in Obesity Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Semaglutide Effectiveness in Obesity Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3; removed Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T00:26:35.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 badge. Removed the government funding operating status notice on the page.
    Difference
    0.2%
    Check dated 2026-02-11T14:35:16.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide funding notice about information accuracy and where to check operating status, and a new revision label (v3.4.1); removed the previous revision label (v3.4.0).
    Difference
    0.2%
    Check dated 2026-02-04T10:42:55.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Adds a glossary display option and updates QC/version metadata (Last Update Submitted that Met QC Criteria and Revision: v3.4.0), while removing the previous No FEAR Act data and Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-28T06:27:45.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4; no visible changes to study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:21:06.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Expanded the Locations section to include multiple US states (Alabama, California, Georgia, Kentucky, Louisiana, Maryland, Michigan, Nebraska, New York, North Carolina, Ohio, Tennessee, Texas, Virginia, Washington) and international sites (Denmark, Israel, the Netherlands, Portugal, Spain, Sweden, South Africa—Gauteng, KwaZulu-Natal, North West), indicating broader site availability.
    Difference
    1%
    Check dated 2025-12-23T10:22:33.000Z thumbnail image

Stay in the know with updates to Semaglutide Effectiveness in Obesity Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Semaglutide Effectiveness in Obesity Clinical Trial page.